Opiranserin
4-butoxy-N-[[4-(dimethylamino)oxan-4-yl]methyl]-3,5-dimethoxybenzamide
Molecular Identity
Opiranserin
4-butoxy-N-[[4-(dimethylamino)oxan-4-yl]methyl]-3,5-dimethoxybenzamide
PubChem CID: 71566778
2D Structure
Properties
C21H34N2O5
Molecular Formula
394.50
Molecular Weight
g/mol
394.2468
Exact Mass
Da
2.6
XLogP
Drug-like (Lipinski: < 5)
69.3
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
6
H-Bond Acceptors
454
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Opiranserin1441000-45-8VVZ-149 free baseAP031EC2NIOPIRANSERIN [INN]UNII-AP031EC2NIOPIRANSERIN [WHO-DD]4-Butoxy-N-((4-(dimethylamino)tetrahydro-2H-pyran-4-yl)methyl)-3,5-dimethoxybenzamideVVZ1494-butoxy-N-[[4-(dimethylamino)oxan-4-yl]methyl]-3,5-dimethoxybenzamideBenzamide, 4-butoxy-N-((4-(dimethylamino)tetrahydro-2H-pyran-4-yl)methyl)-3,5-dimethoxy-4-butoxy-N-{[4-(dimethylamino)oxan-4-yl]methyl}-3,5-dimethoxybenzamide4-Butoxy-N-[[4-(dimethylamino)tetrahydro-2H-pyran-4-yl]methyl]-3,5-dimethoxybenzamideopiranserinaopiranserine
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Opiranserin
Loading drug network...